Loading...

TSBX TURNSTONE BIOLOGICS CORP Management Changes 8-K Filing

TRNS

TSBX

TURNSTONE BIOLOGICS CORP

(TSBX)

2025 8-K

Show Summary

Summary

Appointments, Resignations,...

Merger of Equals

Merger of Equals

Financial Statements

Stock Delisting

Financial Results

Strategic Alternatives

Workforce Reduction

Nasdaq Compliance Notice

Financial Results

Annual Meeting Results

Financial Results Announcement

Departure of Directors

Earnings Reports

Regulation FD Disclosure

Initial Public Offerings

External Links:

Turnstone Biologics Corp. reported that it entered into separation agreements with its CEO, Sammy Farah, on July 17, 2025, and COO, Saryah Azmat, on July 11, 2025, as part of management changes following prior announcements on June 26, 2025.

AI Assistant

TURNSTONE BIOLOGICS CORP

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.